TNF and atrial fibrillation: Despite the limitations presented in the studies, the results observed suggest that LLTS could become a valuable adjunctive treatment for PAF, particularly in patients who experience frequent episodes or are refractory to conventional therapies, improving parameters such as AF burden and TNF-α levels.